celecoxib has been researched along with Cancer of Intestines in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " On short-term administration, the selective COX-2 inhibitor celecoxib inhibits adenoma growth in animal tumor models, including the C57BL/6J-Min/+ (Min/+) mouse." | 3.73 | Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor. ( Bertagnolli, MM; Carothers, AM; Cho, NL; Moran, AE; Redston, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Paton, DJW | 1 |
| Kumarasinghe, MP | 1 |
| Egashira, I | 1 |
| Takahashi-Yanaga, F | 1 |
| Nishida, R | 1 |
| Arioka, M | 1 |
| Igawa, K | 1 |
| Tomooka, K | 1 |
| Nakatsu, Y | 1 |
| Tsuzuki, T | 1 |
| Nakabeppu, Y | 1 |
| Kitazono, T | 1 |
| Sasaguri, T | 1 |
| Ignatenko, NA | 1 |
| Besselsen, DG | 1 |
| Stringer, DE | 1 |
| Blohm-Mangone, KA | 1 |
| Cui, H | 1 |
| Gerner, EW | 1 |
| Cho, NL | 2 |
| Redston, M | 2 |
| Zauber, AG | 1 |
| Carothers, AM | 3 |
| Hornick, J | 1 |
| Wilton, A | 1 |
| Sontag, S | 1 |
| Nishioka, N | 1 |
| Giardiello, FM | 1 |
| Saltzman, JR | 1 |
| Gostout, C | 1 |
| Eagle, CJ | 1 |
| Hawk, ET | 1 |
| Bertagnolli, MM | 3 |
| Davids, JS | 1 |
| Damas, BC | 1 |
| Gandhi, SR | 1 |
| Tiwari, AK | 1 |
| Kunte, DP | 1 |
| De la Cruz, MA | 1 |
| Stypula, Y | 1 |
| Gibson, T | 1 |
| Brasky, J | 1 |
| Backman, V | 1 |
| Wali, RK | 1 |
| Roy, HK | 1 |
| Lubet, RA | 1 |
| Clapper, ML | 1 |
| McCormick, DL | 1 |
| Pereira, MA | 1 |
| Chang, WC | 1 |
| Steele, VE | 1 |
| Fischer, SM | 1 |
| Juliana, MM | 1 |
| Grubbs, CJ | 1 |
| Moran, AE | 1 |
| Talmadge, JE | 1 |
| Hood, KC | 1 |
| Zobel, LC | 1 |
| Shafer, LR | 1 |
| Coles, M | 1 |
| Toth, B | 1 |
1 review available for celecoxib and Cancer of Intestines
| Article | Year |
|---|---|
NSAID-associated submucosal fibrous nodules of the small intestine revisited.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Fibrosis; Hum | 2020 |
1 trial available for celecoxib and Cancer of Intestines
| Article | Year |
|---|---|
Aberrant crypt foci in the adenoma prevention with celecoxib trial.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Biomarkers; Celecoxib; C | 2008 |
7 other studies available for celecoxib and Cancer of Intestines
| Article | Year |
|---|---|
Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway.
Topics: Animals; beta Catenin; Blood Cell Count; Body Weight; Celecoxib; Cell Line, Tumor; DNA Glycosylases; | 2017 |
Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
Topics: Adenoma; Adenomatous Polyposis Coli; Animals; Biogenic Polyamines; Celecoxib; Chemoprevention; Eflor | 2008 |
Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Extracellular Matrix; Female; Fib | 2010 |
Association of stem-like cells in gender-specific chemoprevention against intestinal neoplasia in MIN mouse.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chemoprevention; Disease Models, Animal | 2011 |
Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Bexarotene; Celecoxib; Co | 2012 |
Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor.
Topics: Adenoma; Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Administration Schedule | 2006 |
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion.
Topics: 1,2-Dimethylhydrazine; Adjuvants, Immunologic; Animals; Anticarcinogenic Agents; Arginase; Breast Ne | 2007 |